Abstract
Calcium antagonists have demonstrated efficacy in cardiovascular medicine with clear antihypertensive, antiarrhythmic, and anti-ischemic properties. Due to the widespread use of calcium antagonists for patients with hypertension, arrhythmias, and ischemic heart disease, many patients who are undergoing coronary bypass surgery are often taking these medications. There are also several potential indications to initiate calcium antagonist therapy before, during, or after coronary bypass surgery and these will be addressed in this chapter under the following subheadings:
-
1.
Antihypertensive therapy
-
2.
Anti-arrhythmic therapy
-
3.
Anti-ischemic therapy
-
4.
Anti-atherosclerotic therapy
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boylan JF, O’Leary G, Weisel RD et al (1990) A comparison of diltiazem, esmolol, nifedipine and nitroprusside therapy of post-CABG hypertension. Can J Anesth 6: S156 (abstract).
Lawrence CJ, Lestrade A, deLange S (1991) Isradipine, a calcium antagonist, in the control of hypertension following coronary artery-bypass surgery. Am J Hypertens 4: 207S–209S.
Brister NW, Barnette RE, Schartel SA et al (1991) Isradipine for treatment of acute hypertension after myocardial revascularization. Grit Care Med 19: 334–338.
Underwood SM, Feneck RO, Davies SW et al (1989) Use of isradipine in hypertension following coronary artery bypass surgery. Am J Med 86: 81–87.
Colson P, Medioni P, Saussine M et al (1992) Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery. J Cardiothorac Anesth 6: 424–4428.
Hicks GL, Salley RK, DeWeese JA (1984) Calcium channel blockers: an intraoperative and postoperative trial in women. Ann Thorac Surg 37: 319–322.
Ferraris VA, Ferraris SP, Gilliam HS et al (1991) Predictors of postoperative ventricular dysrhythmias: a multivariate study. J Cardiovasc Surg 32: 12–20.
Gottlieb SO, Ouyang P, Achuff SC et al (1984) Acute nifedipine withdrawal: Consequences of preoperative and late cessation of therapy in patients with prior unstable angina. J Am Coll Cardiol 4: 382–388.
Colson P, Medioni P, Saussine M et al (1992) Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery. J Cardiothorac Vasc Anesth 6(4): 424–428.
Seitelberger R, Zwolfer W, Huber S et al (1991) Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting. Circulation 83: 460–468.
Seitelberger R, Zwolfer W, Binder TM (1990) Infusion of nifedipine following coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia. Ann Thorac Surg 49: 61–68.
Myles PS, Olenikov I, Bujor MA et al (1993) ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study. Med J Aust 158: 675–677.
Becker RC, Alpert JS (1990) The impact of medical therapy on hemorrhagic complications following coronary artery bypass grafting. Arch Int Med 150: 2016–2021.
Henry PD, Bentley KI (1981) Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 68: 1366–1369.
Henry PD (1990) Anti-atherogenic effects of calcium channel blockers: possible mechanisms of action. Cardiovasc Drugs Ther 4: 1015–1020.
Weinstein DB, Helder JG (1987) Antiatherogenic properties of calcium antagonists. Am J Cardiol 59: 163B–172B.
Henry P (1990) Calcium antagonists as anti-atherosclerotic agents. Arteriosclerosis 10: 963–965.
Kober G, Schneider W, Kaltenbach M (1989) Can the progression of coronary sclerosis be influenced by calcium antagonists? J Cardiovasc Pharmacol 13: S2–S6.
Holzgreve H, Burkle B (1993) Anti-atherosclerotic effects of calcium antagonists. J Hypertens 11: 555–559.
Ginsburg R, Davis K, Bristow MR et al (1983) Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteris of cholesterol-fed rabbits. Lab Invest 49: 154–158.
Rouleau JL, Parmley WW, Stevens J et al (1983) Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1: 1453–1460.
Willis AL, Nagel B, Churchill V et al (1985) Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Arteriosclerosis 5: 250–255.
Parmley WW (1990) Vascular protection from atherosclerosis: potential of calcium antagonists. Am J Cardiol 66: 161–221.
Nayler WG, Panagiotopoulos S (1993) The antiatherosclerotic effect of the calcium antagonists and their implications in hypertension. Am Heart J 125: 626–629.
Vos J, DeFeyter PJ, Simoons ML et al (1993) Retardation and arrest of progression or regression of coronary artery disease: a review. Prog Cardiovasc Dis 35: 435–454.
Triggle DJ (1992) Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleve Clin J Med 59: 617–627.
Waters D, Lesperance J, Francetich M et al (1990) A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circ 82: 1940–1953.
Loaldi A, Polese A, Montorsi P et al (1989) Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progressoin and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 64: 433–439.
Gottlieb SO, Brinker JA, Mellits ED et al (1989) Effect of nifedipine on the development of coronary bypass graft stenoses in high-risk patients: a randomized, double-blind, placebo-controlled trial. Circulation 80: 11228 (abstract).
Borhani NO, Brugger SB, Byington RP (1990) Multicenter study with isradipine and diuretics against atherosclerosis. J Cardiovasc Pharmacol 15: S23–S29.
Lichtlen PR, Hugenholtz PG, Rafflenbeul W et al (1990) Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 335: 1109–1113.
Unni KK, Kottke BA, Titus JL et al (1974) Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol 34: 526–532.
Campeau L, Enjalbert M, Lesperance J et al (1984) Risk factors relative to atherosclerosis in saphenous vein bypass grafts and native vessels: a 10-year followup study. N Engl J Med 311: 1329–1332.
Blankenhorn DH, Nessim SA, Johnson RL et al (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240.
Chesebro JH, Fuster V, Elveback LR et al (1984) Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 310: 209–214.
Brown BG, Cukingnan RA, DeRouen T et al (1985) Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation 72: 138–146.
Chesebro JH, Webster MWI, Smith HC et al (1989) Antiplatelet therapy in coronary disease progression: reduced infarction and new lesion formation. Circulation 80: 11266 (abstract).
McCallister BD, Giorgi LV, Ligon R et al (1989) Effectiveness of aortocoronary bypass: a one year angiographic study using diltiazem and antiplatelet therapy. Circulation 80: II392.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gottlieb, S.O. (1994). Calcium Antagonists in Patients Undergoing Coronary Artery Bypass Surgery. In: Lüscher, T.F., Turina, M., Braunwald, E. (eds) Coronary Artery Graft Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78637-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-78637-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78639-6
Online ISBN: 978-3-642-78637-2
eBook Packages: Springer Book Archive